Satoshi Hirakawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Satoshi Hirakawa has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
A. Tanemura
Department of Cell Growth and Tumor Regulation, Ehime Proteo‐Medicine Research Center, Ehime University, Ehime, Japan
1 shared publicationAtsushi Tanemura
Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan
1 shared publicationDontscho Kerjaschki
Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria
1 shared publicationH. Mori
Department of Dermatology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791‐0295, Japan
1 shared publicationHideki Mori
Department of Dermatology, Integrated Center for Sciences, Ehime University Graduate School of Medicine, Ehime, Japan
1 shared publicationHidenori Okazaki
Department of Dermatology, Integrated Center for Sciences, Ehime University Graduate School of Medicine, Ehime, Japan
1 shared publication
Latest Publications
- 28 February 2011
- Published by Elsevier in Journal of Dermatological Science
- Vol. 61 (2) , 85-93
Regulation of pathological lymphangiogenesis requires factors distinct from those governing physiological lymphangiogenesis
- 28 February 2011
- Published by Elsevier in Journal of Dermatological Science
- Vol. 61 (2) , 85-93
Regulation of pathological lymphangiogenesis requires factors distinct from those governing physiological lymphangiogenesis
- 17 September 2010
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 164 (1) , 200-203
Multiple lymphadenopathy as an initial sign of extramammary Paget disease
Extramammary Paget disease (EMPD) often develops in external genitalia. Paget cells can, however, adopt an invasive phenotype and metastasize to regional lymph nodes and beyond, leading to poor patient outcomes. Based on this clinical observation, multiple lymphadenopathy may represent an initial sign of EMPD. To address the potential significance of multiple lymph node swelling in EMPD, we report two patients with cutaneous primary EMPD who showed multiple lymphadenopathy as an initial sign during the clinical course of the disease as well as tumour metastasis. Significantly, marked lymphatic vessel growth was observed in regional lymph nodes that underwent massive tumour cell invasion. Therefore, nodal lymphangiogenesis may promote tumour cell invasion and metastasis to distant organs, including the lymph nodes, emphasizing the clinical relevance of multiple lymphadenopathy.
- 17 September 2010
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 164 (1) , 200-203
Multiple lymphadenopathy as an initial sign of extramammary Paget disease
Extramammary Paget disease (EMPD) often develops in external genitalia. Paget cells can, however, adopt an invasive phenotype and metastasize to regional lymph nodes and beyond, leading to poor patient outcomes. Based on this clinical observation, multiple lymphadenopathy may represent an initial sign of EMPD. To address the potential significance of multiple lymph node swelling in EMPD, we report two patients with cutaneous primary EMPD who showed multiple lymphadenopathy as an initial sign during the clinical course of the disease as well as tumour metastasis. Significantly, marked lymphatic vessel growth was observed in regional lymph nodes that underwent massive tumour cell invasion. Therefore, nodal lymphangiogenesis may promote tumour cell invasion and metastasis to distant organs, including the lymph nodes, emphasizing the clinical relevance of multiple lymphadenopathy.
- 1 November 2009
- Published by Elsevier in The American Journal of Pathology
- Vol. 175 (5) , 2235-2248
Nodal Lymphangiogenesis and Metastasis
- 1 November 2009
- Published by Elsevier in The American Journal of Pathology
- Vol. 175 (5) , 2235-2248
Nodal Lymphangiogenesis and Metastasis
- 20 May 2009
- Published by Wiley in Cancer Science
- Vol. 100 (6) , 983-989
From tumor lymphangiogenesis to lymphvascular niche
Metastasis in sentinel lymph nodes indicates the initial spread of tumors from a primary site. The recent discovery of tumor‐associated growth of lymphatic vessels clarified that tumor lymphangiogenesis actively promotes enhanced draining/sentinel lymph node metastasis. Studies of experimental carcinogenesis have further established that tumors continue to induce lymphangiogenesis in metastatic foci such as draining lymph nodes. Lymphangiogenesis within draining lymph nodes probably contributes to enhanced distant lymph node and distant organ metastases. Lymph node lymphangiogenesis has recently been identified in several human malignancies, such as cutaneous malignant melanoma. Tumor‐associated lymphangiogenesis thus has potential significance not only at the primary site, but also in lymph nodes. Primary tumors induce new lymphatic vessel growth in draining lymph nodes before metastasis. The remarkable enlargement of sinusoidal lymphatic endothelium might facilitate tumor cell transport to the lymph nodes, and potentially contribute to the migration, residence, and/or survival of metastatic tumor cancer stem cells by inducing a specific tumor microenvironment. Therefore, the novel concept of ‘lymphvascular niche’ is proposed herein to explain lymphatic network expansion. This concept might help to improve understanding of the molecular mechanism of lymph node metastasis, and change therapeutic approaches to treating cancer metastasis. (Cancer Sci 2009; 100: 983–989)
- 20 May 2009
- Published by Wiley in Cancer Science
- Vol. 100 (6) , 983-989
From tumor lymphangiogenesis to lymphvascular niche
Metastasis in sentinel lymph nodes indicates the initial spread of tumors from a primary site. The recent discovery of tumor‐associated growth of lymphatic vessels clarified that tumor lymphangiogenesis actively promotes enhanced draining/sentinel lymph node metastasis. Studies of experimental carcinogenesis have further established that tumors continue to induce lymphangiogenesis in metastatic foci such as draining lymph nodes. Lymphangiogenesis within draining lymph nodes probably contributes to enhanced distant lymph node and distant organ metastases. Lymph node lymphangiogenesis has recently been identified in several human malignancies, such as cutaneous malignant melanoma. Tumor‐associated lymphangiogenesis thus has potential significance not only at the primary site, but also in lymph nodes. Primary tumors induce new lymphatic vessel growth in draining lymph nodes before metastasis. The remarkable enlargement of sinusoidal lymphatic endothelium might facilitate tumor cell transport to the lymph nodes, and potentially contribute to the migration, residence, and/or survival of metastatic tumor cancer stem cells by inducing a specific tumor microenvironment. Therefore, the novel concept of ‘lymphvascular niche’ is proposed herein to explain lymphatic network expansion. This concept might help to improve understanding of the molecular mechanism of lymph node metastasis, and change therapeutic approaches to treating cancer metastasis. (Cancer Sci 2009; 100: 983–989)